Product Description: PT-179 is an orthogonal Thalidomide (HY-14658) derivative that targets cereblon without causing off-target degradation effects. PT-179 is able to specifically bind CRBN, form a ternary complex with a target protein fused to a zinc finger (ZF) degron, and mediate the degradation of the tagged protein. For example, PT-179 binds to the ubiquitin ligase substrate receptor cereblon by forming a complex with SD40 and efficiently degrades proteins N- or C-terminally fused to SD40 or SD36 (DC50 for eGFP: 4.5 nM and 14.3 nM). PT-179 can be used to develop compact protein degradation tagging platforms[1].
Applications: Cancer-programmed cell death
Formula: C17H17N3O5
References: [1]Mercer JAM, et al. Continuous evolution of compact protein degradation tags regulated by selective molecular glues. Science. 2024 Mar 15;383(6688):eadk4422.
CAS Number: 2924858-25-1
Molecular Weight: 343.33
Compound Purity: 99.91
Research Area: cancer
Solubility: DMSO : 125 mg/mL (ultrasonic;warming;heat to 60°C)
Target: Ligands for E3 Ligase;Molecular Glues
English
Deutsch
